A
Arontier
Innovative AI-driven solutions targeting cancer treatment through precision medicine and anti-CAF drug development
About Arontier
Arontier operates in the healthcare and biotechnology sector, focusing on leveraging artificial intelligence (AI) to develop innovative treatments for incurable diseases, particularly cancer. The company's core product revolves around precision medicine, which uses AI to tailor medical treatment to the individual characteristics of each patient. Arontier's primary goal is to develop anti-cancer associated fibroblast (CAF) drugs. CAFs are cells within the tumor environment that promote tumor growth and metastasis, making cancer cells more resistant to treatment. By targeting these cells, Arontier aims to make cancer more vulnerable to existing therapies.
Read full description
Arontier serves a diverse range of clients, including hospitals, medical research institutions, and pharmaceutical companies. The company operates in the global healthcare market, which is continually expanding due to advancements in medical technology and increasing healthcare needs.
Arontier's business model is based on research and development (R&D) and collaboration with medical institutions. The company generates revenue through partnerships, grants, and potentially through the commercialization of its developed drugs. By focusing on innovative technology and AI, Arontier aims to stay at the forefront of medical advancements and provide effective solutions for complex health issues.
At a glance
- Founded
- 2017
- Headquarters
- Seoul, South Korea
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
HLB Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arontier on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arontier on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.